CA2057055C - Methode de traitement de processus pathologiques cataboliques associes a l'intestin et de la depression immunitaire de l'hote - Google Patents

Methode de traitement de processus pathologiques cataboliques associes a l'intestin et de la depression immunitaire de l'hote Download PDF

Info

Publication number
CA2057055C
CA2057055C CA002057055A CA2057055A CA2057055C CA 2057055 C CA2057055 C CA 2057055C CA 002057055 A CA002057055 A CA 002057055A CA 2057055 A CA2057055 A CA 2057055A CA 2057055 C CA2057055 C CA 2057055C
Authority
CA
Canada
Prior art keywords
gln
animal
accordance
nitrogen
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002057055A
Other languages
English (en)
Other versions
CA2057055A1 (fr
Inventor
Robert J. Smith
Douglas W. Wilmore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Priority claimed from PCT/US1990/003095 external-priority patent/WO1990014823A1/fr
Publication of CA2057055A1 publication Critical patent/CA2057055A1/fr
Application granted granted Critical
Publication of CA2057055C publication Critical patent/CA2057055C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002057055A 1989-06-02 1990-06-04 Methode de traitement de processus pathologiques cataboliques associes a l'intestin et de la depression immunitaire de l'hote Expired - Lifetime CA2057055C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36038989A 1989-06-02 1989-06-02
US360839 1989-06-02
PCT/US1990/003095 WO1990014823A1 (fr) 1989-06-02 1990-06-04 Procede pour traiter des processus pathologiques cataboliques lies a l'intestin, ainsi que l'insuffisance des defenses d'un hote

Publications (2)

Publication Number Publication Date
CA2057055A1 CA2057055A1 (fr) 1990-12-03
CA2057055C true CA2057055C (fr) 2002-01-15

Family

ID=23417763

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002057055A Expired - Lifetime CA2057055C (fr) 1989-06-02 1990-06-04 Methode de traitement de processus pathologiques cataboliques associes a l'intestin et de la depression immunitaire de l'hote

Country Status (1)

Country Link
CA (1) CA2057055C (fr)

Also Published As

Publication number Publication date
CA2057055A1 (fr) 1990-12-03

Similar Documents

Publication Publication Date Title
US5039704A (en) Method of treating catabolic dysfunction
US5607975A (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
US5397803A (en) Use of glutamine to reduce rate of pathogenic microorganism infection
US4857555A (en) Method of treating catabolic dysfunction
Fuentes-Orozco et al. L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis
US4703062A (en) Parenteral nutrition with medium and long chain triglycerides
CA1285491C (fr) Methode de traitement de troubles cataboliques
Boelens et al. Plasma taurine concentrations increase after enteral glutamine supplementation in trauma patients and stressed rats
AU641403B2 (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
US5292722A (en) Intravenous solution that diminishes body protein loss
Fleming et al. Subject review: total parenteral nutrition
US5763485A (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
Hallberg et al. Surgical treatment of obesity
CA2057055C (fr) Methode de traitement de processus pathologiques cataboliques associes a l'intestin et de la depression immunitaire de l'hote
ABELS et al. Metabolic Abnormalities in Patients with Cancer of the Gastrointestinal Tract: A Review of Recent Studies
Chaikoff et al. On the survival of the completely depancreatized dog
Astre et al. Plasma and jejunal glutamine levels after extensive small bowel resection in dogs
Kirupananthan The role of peptide transporter 1 (PepT1) in maintaining health in neonates
PARKINSON et al. SHORT SMALL‐BOWEL SYNDROME
NO871935L (no) Fremgangsmaate for behandling av katabolisk dysfunksjon.
LUND such as hemorrhagic shock; protein hydrolysates, con¬
Okanottc 70 Hemodynamic effects of temporary hepatic arterial and portal occlusion In degradable starch microsphcres M. Andcrsson.! l-. kclwid, M. Ih'lvind. L. Jonsson,!.. Doinelldl
Evans Tumour necrosis factor as a mediator of endotoxaemia
HK1093016B (en) Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
HK1093016A1 (en) Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry